18681-52-2

Basic information

• Product Name: methylsulfenyl bromide
• Synonyms: methylsulfenyl bromide
• CAS NO: 18681-52-2
• Molecular Formula: CH₃BrS
• Molecular Weight: 0
• Mol File: 18681-52-2.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 89°Cat760mmHg
• Flash Point: 7.6°C
• Appearance: /
• Density: 1.759g/cm³
• Vapor Pressure: 67.3mmHg at 25°C
• Refractive Index: 1.533
• CAS DataBase Reference: methylsulfenyl bromide(CAS DataBase Reference)
• NIST Chemistry Reference: methylsulfenyl bromide(18681-52-2)
• EPA Substance Registry System: methylsulfenyl bromide(18681-52-2)

Safety Data

• Hazardous Substances Data: 18681-52-2(Hazardous Substances Data)

Usage

InChI:InChI=1/CH3BrS/c1-3-2/h1H3

Upstream product

• 75-18-3 dimethylsulfide 
• 624-92-0 Dimethyldisulphide 
• 7175-75-9 methylthio radical 

Downstream Products

• 1147711-13-4 4-methylphenyl 3-methylsulfurylprop-2-yn-1-yl ether 
• 1073343-63-1 C₁₃H₁₉BrN₂OS₂ 
• 84224-66-8 methyl sulfenyl triflate 
• 1073-29-6 2-(methylsulfenyl)phenol 
• 38771-86-7 3-Bromo-3-methyl-2-methylsulfanyl-N-phenyl-butyramide 

Relevant articles and documents

Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues

A shot in the arm for cancer treatment: Two MUC1 tetanus toxoid vaccines were synthesized and induced a strong immune response in mice. The antibodies elicited by the vaccines show a high selectivity for the tumor cells in mammary carcinoma tissues and al

Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing: N -acetyl modified STn derivatives as anticancer vaccines

Glycoprotein MUC1 is an attractive target for anti-tumor vaccine development. However, the weak immunogenicity of MUC1 remains a significant problem. To solve this problem, several STn derivatives with N-acetyl modifications were synthesized and incorporated into a 20-amino acid MUC1 tandem repeat sequence. The modified STn-MUC1 glycopeptides were further connected to a carrier protein keyhole limpet hemocyanin (KLH). The immunological effects of these synthetic vaccine conjugates were evaluated using the BALB/c mouse model. The results showed that vaccine V2 elicited higher titers of antibodies which cross-reacted with the native STn-MUC1 antigen. Moreover, the elicited antisera reacted with the STn-MUC1 antigen-positive tumor cells, indicating that the carbohydrate antigen modification strategy may hold potential to overcome the weak immunogenicity of natural MUC1 glycopeptides.

Design, synthesis and biological evaluation of sulfenimine cephalosporin sulfoxides as β-lactamase inhibitors

Abstract A series of sulfenimine cephalosporin sulfoxide derivatives (7a-v) were designed, synthesized and evaluated for their inhibitory activity against TEM-1 and cephalosporinase in cell-free systems. Some of the tested compounds showed enhanced inhibi

Regioselective deacetylation and glycosylation in the synthesis of the sialyl lewis0 X tetrasaccharide, a key component of the recognition site of PSGL-1

A high-yielding regioselective deprotection of three out of five hydroxy groups of a Lewis X trisaccharide, which proceeds under very mild basic conditions, and a regio- and stereoselective sialylation reaction enable an efficient access to the sialyl Lew